Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Becton Dickinson and Company (BDX)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
3,908.95 -125.50    -3.11%
22/04 - Closed. Currency in MXN ( Disclaimer )
Type:  Equity
Market:  Mexico
ISIN:  US0758871091 
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 3,908.95 - 3,908.95
Becton Dickinson 3,908.95 -125.50 -3.11%

Becton Dickinson and Co Company Profile

 
Get an in-depth profile of Becton Dickinson and Company, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

70000

Equity Type

ORD

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Contact Information

Address 1 Becton Drive
Franklin Lakes, 07417-1880
United States
Phone 201 847 6800
Fax -
Web www.bd.com

Top Executives

Name Age Since Title
Thomas E. Polen 48 2014 President, CEO & Chairman
Bertram Lee Scott 72 2002 Lead Independent Director
Catherine M. Burzik 73 2013 Independent Director
Claire M. Fraser-Liggett 68 2006 Member of Scientific Advisory Board & Independent Director
John A. DeFord 61 2018 Co-Chair of Scientific Advisory Board
Christopher Ian Montague Jones 68 2010 Independent Director
Jeffrey W. Henderson 58 2018 Independent Director
Robert Andrew Eckert 61 2016 Independent Director
Joseph M. Smith - 2021 Senior VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
William M. Brown 61 2022 Independent Director
Joanne Waldstreicher 62 2023 Independent Director
Eric Perakslis - 2022 Member of Scientific Advisory Board
Jay J. Schnitzer - 2022 Member of Scientific Advisory Board
Timothy M. Ring 66 2017 Independent Director
Ken Sands - 2022 Member of Scientific Advisory Board
Carrie L. Byington 60 2021 Independent Director
Martha L. Gray - 2022 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BDX Comments

Write your thoughts about Becton Dickinson and Co
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lars Sheldon
Lars Sheldon Aug 10, 2021 6:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Can someone tell me the difference between this stock and AMBU(danish company). Becides the fact that AMBU is valued 1/5 of BDX…
Reply
0 0
Report
Lode Schepers
andretti3 Apr 15, 2021 1:40PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
anyone an idea for a target?
Reply
0 0
Report
Richard Hueners
Richard Hueners Apr 15, 2021 1:40PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$240
Reply
0 0
Report
Rajeesh Raju
Rajeesh Raju Feb 28, 2021 6:56PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://www.fool.com/investing/2021/02/27/these-3-stocks-big-winners-from-president-biden/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article
Reply
0 0
Report
Rajeesh Raju
Rajeesh Raju Feb 05, 2021 9:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Last chance to get in , DPA will give a big boost in a few weeks.
Reply
0 1
Report
Lode Schepers
andretti3 Feb 05, 2021 9:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Can you show the basis of your comment, please?
Reply
0 0
Report
Rajeesh Raju
Rajeesh Raju Feb 05, 2021 9:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lode Schepers hope we can see it from today👍🏽
Reply
0 0
Report
Lode Schepers
andretti3 Feb 05, 2021 9:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Rajeesh Raju  good luck
Reply
0 0
Report
Rajeesh Raju
Rajeesh Raju Feb 05, 2021 9:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lode Schepers https://www.nasdaq.com/articles/becton-dickinson-gets-eua-for-new-diagnostic-test-2021-02-14
Reply
0 0
Report
Lode Schepers
andretti3 Feb 05, 2021 9:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Rajeesh Raju  Thank you very much. Succes!
Reply
0 0
Report
m mori
m mori Nov 18, 2020 2:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bye bye b d x you stepped on Elon Musk toes
Reply
2 2
Report
Omer Yazici
Omer Yazici Nov 18, 2020 2:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what happened ?
Reply
0 0
Report
Richard Fortin
Richard Fortin Sep 30, 2020 5:31AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://www.biospace.com/article/releases/cardiff-oncology-prices-public-offering-sep-30-2020/
Reply
0 0
Report
Antonio Massabki
Antonio Massabki Sep 18, 2020 10:18PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
300$ by end of 2020
Reply
1 1
Report
Buy Sell
ab56 Feb 06, 2020 2:00PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
We need to see at least 230 before its worth getting into.
Reply
1 2
Report
Nigel Ng
TradePA Apr 24, 2018 1:34PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
insane earnings, insane share price, insane P/E ratio
Reply
4 0
Report
Francois Sauve
Francois Sauve Apr 24, 2018 1:34PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
P/E isn't insane, 91 is without NRI, forward P/E is 20. At 15 it would be a good entry point but the price would have to be $180.
Reply
0 0
Report
Cristiano Gonçalves
Cristiano Gonçalves May 11, 2017 4:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
. I want to know if this asset comes in at 192 this week? What do you guys think?
Reply
0 0
Report
Francois Sauve
Francois Sauve May 11, 2017 4:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I would pull the trigger at $180 with a forward P/E of 15.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email